Awasty Research Network LLC — research payments reported

By program year

5 rows

Year	Kind	Amount	Payments
2023	Research	$16,242	3
2022	Research	$8,043	18
2021	Research	$16,628	33
2020	Research	$9,032	19
2019	Research	$49,081	1

Breakdown

Who paid Research payments · program years 2019–2023

AstraZeneca Pharmaceuticals LP $49,081 1 payment
Esperion Therapeutics, Inc. $45,251 67 payments
AbbVie, Inc. $4,695 6 payments

Studies the money was for Research payments · program years 2019–2023

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Adults With Stable Coronary Heart Disease $49,081 1 payment
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Effects of Bempedoic Acid (Etc-1002) on the Occurrence of Major Cardiovascular Events in Patients With, Or at High Risk For, Cardiovascular Disease Who Are Statin Intolerant $45,251 67 payments
A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men $4,619 5 payments
A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men (TRAVERSE) $76 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.